In Alicante, Avamed Synergy, a forward‑looking technology company based at Distrito Digital facilities, marked a notable milestone with an early achievement in its Fluxus project. The business reached a funding milestone of 800,000 euros in the first stage of its initial investment round, positioning the team at the forefront of smart clinical diagnostics within the precision medicine landscape. This momentum comes as the company advances its mission to deliver high‑impact solutions that blend medical insight with cutting‑edge technology, reinforcing its status in the regional and broader North American privacy‑aware health tech ecosystem.
Beginning February, Avamed Synergy will implement a 38.5‑hour work week for its staff, a shift designed to balance professional responsibilities with personal time. This new schedule translates to a total of 40 hours weekly, and it includes a Friday off that is offered as a voluntary benefit without any impact on salary. The aim is to create healthier work‑life integration while maintaining the company’s maintained pace of innovation and client delivery. The policy reflects a broader trend in modern workplaces that seek to harmonize employee well‑being with organizational performance, especially in high‑demand, knowledge‑driven teams that support advanced diagnostics and data science initiatives.
While government proposals in some regions focus on reducing working hours through legislative measures, Avamed Synergy chose to adopt a similar approach proactively. Speaking about the initiative, Lucas Diez, the CEO and founder, emphasized the company’s long‑standing emphasis on family, personal welfare, and business productivity. He noted that pilot experiments with a four‑day work week had already shown positive outcomes, suggesting that a compressed schedule could sustain or improve productivity among technical staff while enabling more time for learning, collaboration, and rest. Diez stated that the decision aims to deliver a balanced, sustainable workflow that sustains high levels of output and supports ongoing investments in innovation and team development. The company anticipates that this one‑day reduction per week will be absorbed without affecting compensation and will help amortize the performance gains across the team, reinforcing Avamed Synergy’s commitment to responsible growth and a healthy workplace culture. The approach aligns with the company’s broader strategy to recruit and retain skilled professionals who contribute to the rigorous, data‑driven work required for health tech breakthroughs, while ensuring that the organization remains responsive to evolving market dynamics and regulatory considerations.